ESC 365 - Blood pressure targets in current guidelines: what's left unanswered?

Open Access

Blood pressure targets in current guidelines: what's left unanswered?

Session: Blood pressure targets in high risk patients: challenges and opportunities

Topic: Epidemiology, Prognosis, Outcome

Speaker: Professor E. Shlyakhto (Saint-Petersburg, RU)

Event: ESC CONGRESS 2019

Congress Session

About the speaker

Professor Evgeny Shlyakhto

Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg (Russian Federation)

4 presentations

0 follower

4 more presentations in this session

State of the Art - Blood pressure targets in high risk patients : how low to go?

Speaker: Professor S. MacMahon (Oxford, GB)

Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)

Speaker: Doctor M. Pareek (Boston, US)

Different relationships between blood pressures and clinical events in SPRINT and ACCORD-BP trial

Speaker: Associate Professor D. Shin (Seoul, KR)

Is intensive blood pressure strategy effective and safe in patients with cardiovascular disease? The two sides of the coin

Speaker: Doctor D. Terentes-Printzios (Athens, GR)

Access the full session

Blood pressure targets in high risk patients: challenges and opportunities

Speakers: Professor E. Shlyakhto, Professor S. MacMahon, Doctor M. Pareek, Associate Professor D. Shin, Doctor D. Terentes-Printzios

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

Open Access

How should I treat my patient with acute heart failure? - Chat Moderator.

27 August 2021

Open Access

The collateral damage of COVID-19 on CVD – discussion.

27 August 2021

Open Access

COVID-19 and the risk of thrombosis.

27 August 2021

This platform is supported by